Literature DB >> 10022381

Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis.

R van Crevel1, J van der Ven-Jongekrijg, M G Netea, W de Lange, B J Kullberg, J W van der Meer.   

Abstract

As a simple method for field studies to assess the cytokine-status of patients with tuberculosis (TB), the use of whole blood instead of isolated cells has advantages, especially since the risk of contamination is minimal. Therefore, cytokine production in whole blood cultures was determined using non-specific and disease-specific stimuli. Heparinized blood from healthy volunteers was either incubated in closed vacutainer tubes or in tissue culture wells after dilution in culture medium. Dose-response and kinetics were investigated for the production of TNFalpha, IL-1beta, IL-1ra, IL-10 and IFNgamma. Patients with TB and healthy individuals were examined for IFN-gamma production in whole blood. In the absence of a stimulus, the production of cytokines is negligible in whole blood cultures. LPS induces the production of TNFalpha, IL-1beta, IL-1ra and IL-10; PHA induces the production of IFNgamma and IL-10. Live BCG induces the production of proinflammatory cytokines, irrespective of tuberculin skin status. In contrast, PPD and MTB-culture filtrate induce production of IFNgamma in skin-test positive and not in skin-test negative healthy subjects. Five out of 13 patients with TB had a low antigen-specific IFNgamma production, suggestive of a minimal or absent specific T-cell response. For most purposes, cultures in closed vacutainer tubes are optimal. If one wishes to focus on T-cell cytokines or if only small volumes of blood are available, dilution of whole blood in culture medium before incubation in tissue culture wells may be preferable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022381     DOI: 10.1016/s0022-1759(98)00192-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

Review 1.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

2.  Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.

Authors:  S M Arend; A C Engelhard; G Groot; K de Boer; P Andersen; T H Ottenhoff; J T van Dissel
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Gregory Foster; David N McMurray
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 4.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

5.  Modulation of muramyl dipeptide stimulation of cytokine production by blood components.

Authors:  J H M van der Meer; M G Netea; C A Dinarello
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

6.  Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.

Authors:  R Phillips; C Horsfield; S Kuijper; S F Sarfo; J Obeng-Baah; S Etuaful; B Nyamekye; P Awuah; K M Nyarko; F Osei-Sarpong; S Lucas; A H J Kolk; M Wansbrough-Jones
Journal:  Clin Vaccine Immunol       Date:  2006-02

7.  Serum levels of leptin in Nigerian patients with sickle cell anaemia.

Authors:  Bamidele A Iwalokun; Senapon O Iwalokun; Semande O Hodonu; Ayoola O Aina; Phillip U Agomo
Journal:  BMC Blood Disord       Date:  2011-05-26

8.  Cytokine signatures of human whole blood for monitoring immunosuppression.

Authors:  Yi He; Yuwei Luo; Xiaobin Lao; Liping Tan; Erwei Sun
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

9.  Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi.

Authors:  Yang Li; Marije Oosting; Patrick Deelen; Isis Ricaño-Ponce; Sanne Smeekens; Martin Jaeger; Vasiliki Matzaraki; Morris A Swertz; Ramnik J Xavier; Lude Franke; Cisca Wijmenga; Leo A B Joosten; Vinod Kumar; Mihai G Netea
Journal:  Nat Med       Date:  2016-07-04       Impact factor: 53.440

10.  Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures.

Authors:  Lan Zhang; Frank Stuber; Ulrike M Stamer
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.